COMPANY
ReveraGen BioPharma
Timeline
- Trial start Phase 2: A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD) source ↗
- Trial start Phase 1/Phase 2: Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis source ↗
- Trial start Phase 2: A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) source ↗
- Trial start Phase 2: Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) source ↗
- Trial start Phase 2: An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) source ↗
- Trial start Phase 2: A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) source ↗
- Trial start 1: A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects source ↗
Clinical trials (lead sponsor) 7
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05166109 | A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD) | Phase 2 | Completed | Jul 7, 2022 | Aug 18, 2025 (actual) |
| NCT03439670 | A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | Phase 2 | Completed | Jun 29, 2018 | Feb 23, 2021 (actual) |
| NCT03038399 | Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | Phase 2 | Completed | Feb 2, 2017 | Apr 30, 2020 (actual) |
| NCT04348890 | Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis | Phase 1/Phase 2 | Withdrawn | Sep 1, 2020 | Sep 1, 2022 (estimated) |
| NCT02760277 | An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | Phase 2 | Completed | Jul 28, 2016 | Apr 26, 2018 (actual) |
| NCT02760264 | A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | Phase 2 | Completed | 2016-06 | May 1, 2018 (actual) |
| NCT02415439 | A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects | 1 | Completed | 2015-01 | 2015-11 (actual) |